Unique ID issued by UMIN | UMIN000035176 |
---|---|
Receipt number | R000040034 |
Scientific Title | prospective study of whether residual urine volume will affect adverse events of BCG instillation therapy for non-muscle invasive bladder cancer |
Date of disclosure of the study information | 2018/12/10 |
Last modified on | 2023/06/13 21:40:01 |
prospective study of whether residual urine volume will affect adverse events of BCG instillation therapy for non-muscle invasive bladder cancer
prospective study of whether residual urine volume will affect adverse events of BCG instillation therapy for non-muscle invasive bladder cancer
prospective study of whether residual urine volume will affect adverse events of BCG instillation therapy for non-muscle invasive bladder cancer
prospective study of whether residual urine volume will affect adverse events of BCG instillation therapy for non-muscle invasive bladder cancer
Japan |
non-muscle invasive bladder cancer
Urology |
Malignancy
NO
Optimization of BCG intravesical injection therapy for non-muscle invasive bladder cancer
Safety,Efficacy
Confirmatory
Not applicable
The primary end point was adverse events and quality of life during enforcement.
We assessed QOL using the EORTC QLQ-C30 before start of BCG, after completion or dropout.
The secondary endpoints are complications, enforcement frequency and recurrence.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
patients with non-muscle invasive bladder cancer
1)Age: over 20 years old, gender does not matter
2)Patients with ECOG PS 0 or 1
3)Patients who are expected to survive for more than 2 years
4)Patient with document informed consent
5)Patients who are not taking other treatments for bladder cancer
1)The case with serious complications
2)The case with active double cancer
3)The case with pregnancy,lactation or possibility of pregnancy
4)The case with drug allergy for BCG
5)The case with History of HIV infection, patients with active chronic hepatitis by hepatitis B or C virus
6)Patients with active infection (grade 3 or higher according to CTCAE Version 4.0)
7)The case without the selection criteria
100
1st name | Wataru |
Middle name | |
Last name | Obara |
Iwate Medical University
Urology
0200023
19-1 Uchimaru,Morioka,Iwate
0196515111
watao@iwate-med.ac.jp
1st name | Yoichiro |
Middle name | |
Last name | Kato |
Iwate Medical University
Urology
0200023
19-1 Uchimaru,Morioka,Iwate
0196515111
j2c789@bma.biglobe.ne.jp
Iwate Medical University
iwate medical university
Other
iwate medical university
19-1 Uchimaru,Morioka,Iwate
0196515111
d199212k@gmail.com
NO
2018 | Year | 12 | Month | 10 | Day |
https://journals.sagepub.com/eprint/RITKHGZ58MDZTKISP2ZC/full
Partially published
https://journals.sagepub.com/eprint/RITKHGZ58MDZTKISP2ZC/full
69
43 patients were in the SPVR group and 26 patients were in the LPVR group.
In the QOL analyses, cognitive function and emotional function in the functional scale and fatigue, nausea/vomiting, and dyspnoea in the symptomatic scale were worse in the SPVR group than in the LPVR group. In the multivariate analysis, fatigue was worse in the SPVR group than in the LPVR group.
2022 | Year | 01 | Month | 31 | Day |
69 patients were analysed .57 male and 12 female,mean age, 72.7 years.
The EORTC QLQ-C30 scores for all patients in this study and IPSS scores for some patients who received IPSS analysis were assessed before and after BCG instillation therapy. Patients who dropped out because of an adverse event were assessed the day of withdrawal.
Hematuria, pain
EORTCQLQ-C30,IPSS,post voiding residual volume
Completed
2018 | Year | 06 | Month | 25 | Day |
2018 | Year | 06 | Month | 25 | Day |
2018 | Year | 06 | Month | 25 | Day |
2020 | Year | 03 | Month | 31 | Day |
Self-urination finished before administration of BCG.
Urine discharged at the time of urethral catheterization is measured every time as residual urine.
We assessed QOL using the EORTC QLQ-C30 before start of BCG, after completion or dropout.
2018 | Year | 12 | Month | 07 | Day |
2023 | Year | 06 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040034
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |